Atea Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Atea Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q4 2024.
  • Atea Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $1.24M, a 32% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.24M -$585K -32% Dec 31, 2024 10-K 2025-03-06
Q3 2024 $1.39M -$579K -29.4% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.54M -$573K -27.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.68M -$567K -25.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.83M -$561K -23.5% Dec 31, 2023 10-K 2025-03-06
Q3 2023 $1.97M -$556K -22% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.11M -$575K -21.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.25M -$639K -22.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.39M +$2.23M +1384% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.53M +$2.3M +1013% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.69M +$2.39M +817% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.89M +$2.53M +712% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $161K Dec 31, 2021 10-K 2023-02-28
Q3 2021 $227K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $293K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $356K Mar 31, 2021 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.